Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

High materiality9/10

Astrana Health reports record Q3 revenue and 2027 payer growth catalysts

Nov 5, 2026, 4:23 PM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Strong quarterly beat, scalable AI platform, and visible 2027 payer growth likely to drive multiple expansion and positive sentiment, similar to other healthcare tech peers delivering enterprise-scale value.

AI summary

What happened, with direct paths to the underlying reporting

Astrana Health†s Q3 results show record revenue and EBITDA as its AI-native platform scales with Care Partners and Care Enablement. The Georgia IPA acquisition closed, along with new Medicare Advantage partnerships for 2027, signals faster growth and expanded payer reach. Management maintains guidance for 2026 with growth-driven execution toward 2027.

Q3 2026 revenue $1,023.6M; YoY +7%, EBITDA $77.2M, +13%.
Nine months revenue $2,961.2M; Adjusted EBITDA $212.4M; EPS $2.25.
Georgia IPA acquisition closed on Oct 1, 2026.
Medicare Advantage partnerships for 2027 across CA, TX, AZ.
2026 guidance narrowed: Q4 revenue $939-1,039M; EBITDA $48.5-61.5M; FCF $107.5-130M.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.